Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Acquisitions (2019 - 2025)

AdaptHealth has reported Acquisitions over the past 7 years, most recently at $23.8 million for Q4 2025.

  • Quarterly results put Acquisitions at $23.8 million for Q4 2025, up 149.76% from a year ago — trailing twelve months through Dec 2025 was $33.4 million (up 249.76% YoY), and the annual figure for FY2025 was $42.4 million, up 344.4%.
  • Acquisitions for Q4 2025 was $23.8 million at AdaptHealth, up from $9.5 million in the prior quarter.
  • Over the last five years, Acquisitions for AHCO hit a ceiling of $1.2 billion in Q1 2021 and a floor of $12000.0 in Q3 2023.
  • Median Acquisitions over the past 5 years was $11.0 million (2022), compared with a mean of $120.9 million.
  • Biggest five-year swings in Acquisitions: soared 6956.91% in 2021 and later plummeted 99.75% in 2022.
  • AdaptHealth's Acquisitions stood at $202.4 million in 2021, then crashed by 98.58% to $2.9 million in 2022, then crashed by 38.61% to $1.8 million in 2023, then soared by 438.76% to $9.5 million in 2024, then soared by 149.76% to $23.8 million in 2025.
  • The last three reported values for Acquisitions were $23.8 million (Q4 2025), $9.5 million (Q4 2024), and $1.8 million (Q4 2023) per Business Quant data.